MycoBiomDB – Record Details (MyCo_2334)

Biomarker Record Details

Database ID: MyCo_2334
DB IDMyCo_2334
TitleInter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis
Year2003
PMID12915817
Fungal Diseases involvedFungal sepsis
Associated Medical ConditionNone
GenusNone
SpeciesNone
OrganismNone
Ethical StatementThe Investigational Review Board for protection of human subjects approved all studies.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourcePlasma
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIaIp
Biomarker Full NameInter-a inhibitor protein (IaIp)
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationRhode Island
CohortUmbilical cord and peripheral blood samples from 139 healthy nonseptic infants of different gestational ages were collected to establish the range of normal IaIp levels in neonates. Matching peripheral blood samples from 10 healthy infants and their mothers were also collected to investigate the correlation between both groups.
Cohort No.139 cases + 10 Controls
Age Group24-42 weeks
P Valuep<.0001
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismBacterial/Fungal infection remains an important cause of morbidity and mortality in both term and preterm newborns. The pathogenesis of the neonatal predilection to infection is multifactorial and includes humoral, phagocytic, and cellular deficiencies. Early identification of septicemia is crucial for successful treatment and outcome in infected neonates. However, the symptoms are often nonspecific and begin unexpectedly; therefore, the clinical and laboratory investigation must start promptly. Antimicrobial therapy is usually initiated empirically before the results of bacteriological tests are available. Reliable and accurate markers that identify infants with neonatal sepsis are needed to reduce unnecessary use of antibiotics and the risk of emerging bacterial/fungal resistance in newborn nurseries.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsNone
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationDecrease
Sequence DataNone
External LinkNone